Research And Development Tenders

Open House Contracts 2024-2

Open House Drug Discount Agreements Rivaroxaban Film-Coated Tablets (Except with a Strength of 2.5 Mg), Atc B01af01

Open House Drug Discount Contracts in Accordance with Section 130A Paragraph 8C Sgb V Pemetrexed, Atc L01ba04

Open House Drug Discount Contracts in Accordance with Section 130A Paragraph 8C Sgb V Bortezomib, Atc L01xg01

Drug Contracts with an Option to Join

Commissioning Actors to Take Part in State Examinations

Openhouse Procedure Dressing Materials

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion Within the Framework of the So-Called Open House Procedure.

Medicines with the Active Ingredient Combination Vilanterol, Umeclidinium Bromide and Fluticasone Furoate (Atc: R03al08)

Medicines with the Active Ingredient Combination Formoterol, Glycopyrronium Bromide and Beclometasone (Atc: R03al09)